Title: Evaluation of standardization capability of current cardiac troponin I assays by a correlation study: results of an IFCC pilot project
Authors: TATE JilianBUNK DavidCHRISTENSON RobertBARTH JulianKATRUKHA AlexeiNOBLE James E.SCHIMMEL HeinzWANG LiliPANTEGHINI M.
Citation: CLINICAL CHEMISTRY AND LABORATORY MEDICINE vol. 53 no. 5 p. 677-690
Publisher: WALTER DE GRUYTER GMBH
Publication Year: 2015
JRC N°: JRC90951
ISSN: 1434-6621
URI: http://www.degruyter.com/view/j/cclm.2015.53.issue-5/cclm-2014-1197/cclm-2014-1197.xml
http://publications.jrc.ec.europa.eu/repository/handle/JRC90951
DOI: 10.1515/cclm-2014-1197
Type: Articles in periodicals and books
Abstract: Background: As a part of an International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) project to prepare a commutable reference material for cardiac troponin I (cTnI), a pilot study evaluated current cTnI assays for measurement equivalence and their standardization capability. Methods: cTnI-positive samples collected from 90 patients with suspected acute myocardial infarction were assessed for method comparison by 16 cTnI commercial assays according to predefined testing protocols. Seven serum pools prepared from these samples were also assessed. Results: Each assay was assessed against median cTnI concentrations measured by 16 cTnI assays using Passing-Bablok regression analysis of 79 patient samples with values above each assay’s declared detection limit. We observed a 10-fold difference in cTnI concentrations for lowest to highest measurement results. After mathematical recalibration of assays, the between-assay variation for patient samples reduced on average from 40% to 22% at low cTnI concentration, 37%–20% at medium concentration, and 29%–14% at high concentration. The average reduction for pools was larger at 16%, 13% and 7% for low, medium and high cTnI concentrations, respectively. Overall, assays demonstrated negligible bias after recalibration (y-intercept: –1.4 to 0.3 ng/L); however, a few samples showed substantial positive and/or negative differences for individual cTnI assays. Conclusions: All of the 16 commercial cTnI assays evaluated in the study demonstrated a significantly higher degree of measurement equivalence after mathematical recalibration, indicating that measurement harmonization or standardization would be effective at reducing inter-assay bias. Pooled sera behaved similarly to individual samples in most assays.
JRC Directorate:Health, Consumers and Reference Materials

Files in This Item:
There are no files associated with this item.


Items in repository are protected by copyright, with all rights reserved, unless otherwise indicated.